Pfizer Inc.
STABLE AQUEOUS ANTIBODY FORMULATION
Last updated:
Abstract:
The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti-vascular endothelial growth factor (VEGF) antibody.
Status:
Application
Type:
Utility
Filling date:
6 Jan 2021
Issue date:
6 May 2021